Advertisement
Advertisement
Trending on Urology Times
1
FDA updates in urology: May 2026
2
Pedro Barata, MD, highlights phase 3 data on 177Lu-rosopatamab tetraxetan in mCRPC
3
Tanya B. Dorff, MD, highlights early data on ABBV-969 in mCRPC
4
TALAPRO-3: Talazoparib plus enzalutamide improves rPFS in HRR gene-altered mCSPC
5